All Clinical Trials
Mater conducts clinical trials in a range of therapeutic areas including Cance, Nerouology, Medicine, Orthopaedics Surgery and Acute Care, and Mothers' and Babies Health. Clinical trials are an essential component of helathcare. They provide the evidence to evaluate the safety and efficacy of new treantments and diagnositics, and provide alternative treatment options for patients with unmet needs.
Medical Oncology Trials
The Medical Oncology Clinical Research team, based within the Mater Cancer Care Centre, currently has 22 actively recruiting trials.
Medicinal cannabis for palliative care patients - exploring detection of cannabis in saliva, urine and blood tests.
Medicinal cannabis for advanced cancer patients – driving implications.
MK-1654 - Prophylactic treatment to prevent Respiratory Syncytial Virus infection in infants
A Phase 3, Multicenter, Randomized, Partially Blinded, Palivizumab Controlled Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of MK-1654 in Infants and Children at Increased Risk for Severe RSV Disease.
Nimble - Possible new medicine for Adults and Adolescents with Eosinophilic Asthma
A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype.
Optimising positioning for infants born with Congenital Diaphragmatic Hernia
Using Electrical Impedance Tomography to Evaluate the Effect of Positioning in Neonates with Congenital Diaphragmatic Hernias.
PACIFIC-9
A Phase III, double-blind, placebo-controlled, Randomised, Multicentre, International Study of Durvalumab Plus Oleclumab and Durvalumab Plus Monalizumab in Patients With Locally Advanced (Stage III), Unresectable Non-small Cell Lung Cancer (NSCLC) Who Have Not Progressed Following Definitive, Platinum-Based Concurrent Chemoradiation Therapy.
Palekona - An oral treatment for Ulcerative Colitis
Study of GS-5290 in participants with moderately to severely active ulcerative colitis
PARAGON-II
This trial is for people with gynaecological cancers whose tumours are potentially treatable with endocrine treatment.
Phenylketonuria (PKU): An early phase trial of a new treatment for PKU
This study is trialing a novel drug, called JNT-517, which works by increasing excretion of phenylalanine in the urine to reduce circulating levels in the blood.
Pilaster - New add on therapy to help treat chronic obstructive pulmonary disease with chronic bronchitis
Evaluate the Efficacy and Safety of 2 Doses of CHF6001 DPI (Tanimilast), as add-on to Maintenance Triple Therapy in Subjects With Chronic obstructive pulmonary disease (COPD) and Chronic Bronchitis.